Snake Anti-venom Immunoglobulin Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Type (Polyvalent Anti-venom Immunoglobulin, Monovalent Anti-venom Immunoglobulin); Application (Non-profit Institutions, Hospitals, Clinics) and Geography

Report Code: TIPRE00024651 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming

Covid
Assesing the covid-19 impact?
Get the Latest COVID-19 Analysis on this market
Request Now
Happy to join you in your fight against the COVID-19 economic pandemic!
MARKET OVERVIEW

Snake anti-venom immunoglobulin is a biological product and the only therapeutic medicine that is used for the treatment of venomous snake bites. This is a medication made from antibodies by extracting venom from the snakes. Anti-venoms can either prevent or reverse most of the snakebite envenoming effects. They play a crucial role in minimizing mortality and morbidity.

MARKET SCOPE

The "Global Snake Anti-venom Immunoglobulin Market Analysis to 2028" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of the snake anti-venom immunoglobulin market with detailed market segmentation by type, application and geography. The report provides key statistics on the market status of the leading snake anti-venom immunoglobulin market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION

  •  Based on type, the global snake anti-venom immunoglobulin market is segmented into polyvalent anti-venom immunoglobulin, and monovalent anti-venom immunoglobulin.
  •  On the basis of application, the market is bifurcated into non-profit institutions, hospitals and clinic.

MARKET DYNAMICS
Drivers:

  •  Increasing incidences of snake bites and rising awareness about anti-venom drive the snake anti-venom immunoglobulin market.
  •  Growing R&D investments and increasing government initiatives and funding for development of high quality anti-venom boosts the market growth.
  •  Growing technological advancements fuel the market growth.

Restraints:

  •  High cost of anti-venom.
  •  Lack of regulatory capacity for the anti-venoms control.

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides an overview and forecast of the global market based on various segments. It also provides market size and forecast estimates from the year 2019 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), the Middle East and Africa (MEA), and South America. The snake anti-venom immunoglobulin market by each region is later sub-segmented by respective countries and segments. The report covers the analysis and forecast of 18 countries globally along with the current trend and opportunities prevailing in the region.

The report analyzes factors affecting the market from both demand and supply side and further evaluates market dynamics affecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA, and South America after evaluating political, economic, social and technological factors affecting the snake anti-venom immunoglobulin market in these regions.

IMPACT OF COVID-19 ON SNAKE ANTI-VENOM IMMUNOGLOBULIN MARKET

COVID-19 first began in Wuhan (China) during December 2019, and since then, it has spread at a fast pace across the globe. The US, India, Brazil, Russia, France, UK, Turkey, Italy, and Spain are some of the worst affected countries in terms of confirmed cases and reported deaths. Due to the COVID-19 pandemic, there was significant surge in cases of snakebite deaths and cases of disability in few areas because of non-availability of life-saving healthcare services for snakebite. This results in creating a substantial demand for anti-venoms. As both snake bites cases and coronavirus infected patients require ICU admission, hence governments are more focused towards making availability of mechanical ventilation, ICU beds and oxygen supply for the covid patients. The research and development of all the companies are deployed for COVID-19 research, so there has been very little or no research going on in this segment and also hospitals gear up for responding primarily to the upsurge of COVID-19 cases which is going to affect the market growth to a certain extent. Although, due to increased number of snakebites cases, the market may witness slow and steady growth once the pandemic subsides.



Get more information on this report :

MARKET PLAYERS


The report covers key developments in the snake anti-venom immunoglobulin market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for the expansion of business and customer base of market players. The market players from snake anti-venom immunoglobulin market are anticipated to have lucrative growth opportunities in the future with the rising demand for snake anti-venom immunoglobulin in the global market.

The report also includes the profiles of key companies along with their SWOT analysis and market strategies in the snake anti-venom immunoglobulin market. In addition, the report focuses on leading industry players with information such as company profiles, components, and services offered, financial information of the last 3 years, the key development in the past five years.

  •  CSL
  •  Merck
  •  Rare Disease Therapeutics
  •  Flynn Pharma
  •  BTG
  •  Pfizer
  •  Haffkine Bio-Pharmaceutical
  •  MicroPharm
  •  Vins Bioproducts
  •  Bharat Serums and Vaccines
The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.


Get more information on this report :

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Snake Anti-venom Immunoglobulin Market - By Type
1.3.2 Snake Anti-venom Immunoglobulin Market - By Application
1.3.3 Snake Anti-venom Immunoglobulin Market - By Region
1.3.3.1 By Country

2. KEY TAKEAWAYS

3. RESEARCH METHODOLOGY

4. SNAKE ANTI-VENOM IMMUNOGLOBULIN MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PORTER'S FIVE FORCES ANALYSIS
4.2.1 Bargaining Power of Buyers
4.2.1 Bargaining Power of Suppliers
4.2.1 Threat of Substitute
4.2.1 Threat of New Entrants
4.2.1 Competitive Rivalry
4.3. EXPERT OPINIONS

5. SNAKE ANTI-VENOM IMMUNOGLOBULIN MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS

6. SNAKE ANTI-VENOM IMMUNOGLOBULIN MARKET - GLOBAL MARKET ANALYSIS
6.1. SNAKE ANTI-VENOM IMMUNOGLOBULIN - GLOBAL MARKET OVERVIEW
6.2. SNAKE ANTI-VENOM IMMUNOGLOBULIN - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING/MARKET SHARE

7. SNAKE ANTI-VENOM IMMUNOGLOBULIN MARKET - REVENUE AND FORECASTS TO 2028 - TYPE
7.1. OVERVIEW
7.2. TYPE MARKET FORECASTS AND ANALYSIS
7.3. POLYVALENT ANTI-VENOM IMMUNOGLOBULIN
7.3.1. Overview
7.3.2. Polyvalent Anti-venom Immunoglobulin Market Forecast and Analysis
7.4. MONOVALENT ANTI-VENOM IMMUNOGLOBULIN
7.4.1. Overview
7.4.2. Monovalent Anti-venom Immunoglobulin Market Forecast and Analysis
8. SNAKE ANTI-VENOM IMMUNOGLOBULIN MARKET - REVENUE AND FORECASTS TO 2028 - APPLICATION
8.1. OVERVIEW
8.2. APPLICATION MARKET FORECASTS AND ANALYSIS
8.3. NON-PROFIT INSTITUTIONS
8.3.1. Overview
8.3.2. Non-profit Institutions Market Forecast and Analysis
8.4. HOSPITALS
8.4.1. Overview
8.4.2. Hospitals Market Forecast and Analysis
8.5. CLINICS
8.5.1. Overview
8.5.2. Clinics Market Forecast and Analysis

9. SNAKE ANTI-VENOM IMMUNOGLOBULIN MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Snake Anti-venom Immunoglobulin Market Overview
9.1.2 North America Snake Anti-venom Immunoglobulin Market Forecasts and Analysis
9.1.3 North America Snake Anti-venom Immunoglobulin Market Forecasts and Analysis - By Type
9.1.4 North America Snake Anti-venom Immunoglobulin Market Forecasts and Analysis - By Application
9.1.5 North America Snake Anti-venom Immunoglobulin Market Forecasts and Analysis - By Countries
9.1.5.1 Canada Snake Anti-venom Immunoglobulin Market
9.1.5.1.1 Canada Snake Anti-venom Immunoglobulin Market by Type
9.1.5.1.2 Canada Snake Anti-venom Immunoglobulin Market by Application
9.1.5.2 Mexico Snake Anti-venom Immunoglobulin Market
9.1.5.2.1 Mexico Snake Anti-venom Immunoglobulin Market by Type
9.1.5.2.2 Mexico Snake Anti-venom Immunoglobulin Market by Application
9.1.5.3 US Snake Anti-venom Immunoglobulin Market
9.1.5.3.1 US Snake Anti-venom Immunoglobulin Market by Type
9.1.5.3.2 US Snake Anti-venom Immunoglobulin Market by Application
9.2. EUROPE
9.2.1 Europe Snake Anti-venom Immunoglobulin Market Overview
9.2.2 Europe Snake Anti-venom Immunoglobulin Market Forecasts and Analysis
9.2.3 Europe Snake Anti-venom Immunoglobulin Market Forecasts and Analysis - By Type
9.2.4 Europe Snake Anti-venom Immunoglobulin Market Forecasts and Analysis - By Application
9.2.5 Europe Snake Anti-venom Immunoglobulin Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Snake Anti-venom Immunoglobulin Market
9.2.5.1.1 Germany Snake Anti-venom Immunoglobulin Market by Type
9.2.5.1.2 Germany Snake Anti-venom Immunoglobulin Market by Application
9.2.5.2 France Snake Anti-venom Immunoglobulin Market
9.2.5.2.1 France Snake Anti-venom Immunoglobulin Market by Type
9.2.5.2.2 France Snake Anti-venom Immunoglobulin Market by Application
9.2.5.3 Italy Snake Anti-venom Immunoglobulin Market
9.2.5.3.1 Italy Snake Anti-venom Immunoglobulin Market by Type
9.2.5.3.2 Italy Snake Anti-venom Immunoglobulin Market by Application
9.2.5.4 Spain Snake Anti-venom Immunoglobulin Market
9.2.5.4.1 Spain Snake Anti-venom Immunoglobulin Market by Type
9.2.5.4.2 Spain Snake Anti-venom Immunoglobulin Market by Application
9.2.5.5 United Kingdom Snake Anti-venom Immunoglobulin Market
9.2.5.5.1 United Kingdom Snake Anti-venom Immunoglobulin Market by Type
9.2.5.5.2 United Kingdom Snake Anti-venom Immunoglobulin Market by Application
9.2.5.6 Rest of Europe Snake Anti-venom Immunoglobulin Market
9.2.5.6.1 Rest of Europe Snake Anti-venom Immunoglobulin Market by Type
9.2.5.6.2 Rest of Europe Snake Anti-venom Immunoglobulin Market by Application
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Snake Anti-venom Immunoglobulin Market Overview
9.3.2 Asia-Pacific Snake Anti-venom Immunoglobulin Market Forecasts and Analysis
9.3.3 Asia-Pacific Snake Anti-venom Immunoglobulin Market Forecasts and Analysis - By Type
9.3.4 Asia-Pacific Snake Anti-venom Immunoglobulin Market Forecasts and Analysis - By Application
9.3.5 Asia-Pacific Snake Anti-venom Immunoglobulin Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Snake Anti-venom Immunoglobulin Market
9.3.5.1.1 Australia Snake Anti-venom Immunoglobulin Market by Type
9.3.5.1.2 Australia Snake Anti-venom Immunoglobulin Market by Application
9.3.5.2 China Snake Anti-venom Immunoglobulin Market
9.3.5.2.1 China Snake Anti-venom Immunoglobulin Market by Type
9.3.5.2.2 China Snake Anti-venom Immunoglobulin Market by Application
9.3.5.3 India Snake Anti-venom Immunoglobulin Market
9.3.5.3.1 India Snake Anti-venom Immunoglobulin Market by Type
9.3.5.3.2 India Snake Anti-venom Immunoglobulin Market by Application
9.3.5.4 Japan Snake Anti-venom Immunoglobulin Market
9.3.5.4.1 Japan Snake Anti-venom Immunoglobulin Market by Type
9.3.5.4.2 Japan Snake Anti-venom Immunoglobulin Market by Application
9.3.5.5 South Korea Snake Anti-venom Immunoglobulin Market
9.3.5.5.1 South Korea Snake Anti-venom Immunoglobulin Market by Type
9.3.5.5.2 South Korea Snake Anti-venom Immunoglobulin Market by Application
9.3.5.6 Rest of Asia-Pacific Snake Anti-venom Immunoglobulin Market
9.3.5.6.1 Rest of Asia-Pacific Snake Anti-venom Immunoglobulin Market by Type
9.3.5.6.2 Rest of Asia-Pacific Snake Anti-venom Immunoglobulin Market by Application
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Snake Anti-venom Immunoglobulin Market Overview
9.4.2 Middle East and Africa Snake Anti-venom Immunoglobulin Market Forecasts and Analysis
9.4.3 Middle East and Africa Snake Anti-venom Immunoglobulin Market Forecasts and Analysis - By Type
9.4.4 Middle East and Africa Snake Anti-venom Immunoglobulin Market Forecasts and Analysis - By Application
9.4.5 Middle East and Africa Snake Anti-venom Immunoglobulin Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Snake Anti-venom Immunoglobulin Market
9.4.5.1.1 South Africa Snake Anti-venom Immunoglobulin Market by Type
9.4.5.1.2 South Africa Snake Anti-venom Immunoglobulin Market by Application
9.4.5.2 Saudi Arabia Snake Anti-venom Immunoglobulin Market
9.4.5.2.1 Saudi Arabia Snake Anti-venom Immunoglobulin Market by Type
9.4.5.2.2 Saudi Arabia Snake Anti-venom Immunoglobulin Market by Application
9.4.5.3 U.A.E Snake Anti-venom Immunoglobulin Market
9.4.5.3.1 U.A.E Snake Anti-venom Immunoglobulin Market by Type
9.4.5.3.2 U.A.E Snake Anti-venom Immunoglobulin Market by Application
9.4.5.4 Rest of Middle East and Africa Snake Anti-venom Immunoglobulin Market
9.4.5.4.1 Rest of Middle East and Africa Snake Anti-venom Immunoglobulin Market by Type
9.4.5.4.2 Rest of Middle East and Africa Snake Anti-venom Immunoglobulin Market by Application
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Snake Anti-venom Immunoglobulin Market Overview
9.5.2 South and Central America Snake Anti-venom Immunoglobulin Market Forecasts and Analysis
9.5.3 South and Central America Snake Anti-venom Immunoglobulin Market Forecasts and Analysis - By Type
9.5.4 South and Central America Snake Anti-venom Immunoglobulin Market Forecasts and Analysis - By Application
9.5.5 South and Central America Snake Anti-venom Immunoglobulin Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Snake Anti-venom Immunoglobulin Market
9.5.5.1.1 Brazil Snake Anti-venom Immunoglobulin Market by Type
9.5.5.1.2 Brazil Snake Anti-venom Immunoglobulin Market by Application
9.5.5.2 Argentina Snake Anti-venom Immunoglobulin Market
9.5.5.2.1 Argentina Snake Anti-venom Immunoglobulin Market by Type
9.5.5.2.2 Argentina Snake Anti-venom Immunoglobulin Market by Application
9.5.5.3 Rest of South and Central America Snake Anti-venom Immunoglobulin Market
9.5.5.3.1 Rest of South and Central America Snake Anti-venom Immunoglobulin Market by Type
9.5.5.3.2 Rest of South and Central America Snake Anti-venom Immunoglobulin Market by Application

10. INDUSTRY LANDSCAPE
10.1. MERGERS AND ACQUISITIONS
10.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
10.3. NEW PRODUCT LAUNCHES
10.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS

11. SNAKE ANTI-VENOM IMMUNOGLOBULIN MARKET, KEY COMPANY PROFILES
11.1. CSL
11.1.1. Key Facts
11.1.2. Business Description
11.1.3. Products and Services
11.1.4. Financial Overview
11.1.5. SWOT Analysis
11.1.6. Key Developments
11.2. MERCK
11.2.1. Key Facts
11.2.2. Business Description
11.2.3. Products and Services
11.2.4. Financial Overview
11.2.5. SWOT Analysis
11.2.6. Key Developments
11.3. RARE DISEASE THERAPEUTICS
11.3.1. Key Facts
11.3.2. Business Description
11.3.3. Products and Services
11.3.4. Financial Overview
11.3.5. SWOT Analysis
11.3.6. Key Developments
11.4. FLYNN PHARMA
11.4.1. Key Facts
11.4.2. Business Description
11.4.3. Products and Services
11.4.4. Financial Overview
11.4.5. SWOT Analysis
11.4.6. Key Developments
11.5. BTG
11.5.1. Key Facts
11.5.2. Business Description
11.5.3. Products and Services
11.5.4. Financial Overview
11.5.5. SWOT Analysis
11.5.6. Key Developments
11.6. PFIZER
11.6.1. Key Facts
11.6.2. Business Description
11.6.3. Products and Services
11.6.4. Financial Overview
11.6.5. SWOT Analysis
11.6.6. Key Developments
11.7. HAFFKINE BIO-PHARMACEUTICAL
11.7.1. Key Facts
11.7.2. Business Description
11.7.3. Products and Services
11.7.4. Financial Overview
11.7.5. SWOT Analysis
11.7.6. Key Developments
11.8. MICROPHARM
11.8.1. Key Facts
11.8.2. Business Description
11.8.3. Products and Services
11.8.4. Financial Overview
11.8.5. SWOT Analysis
11.8.6. Key Developments
11.9. VINS BIOPRODUCTS
11.9.1. Key Facts
11.9.2. Business Description
11.9.3. Products and Services
11.9.4. Financial Overview
11.9.5. SWOT Analysis
11.9.6. Key Developments
11.10. BHARAT SERUMS AND VACCINES
11.10.1. Key Facts
11.10.2. Business Description
11.10.3. Products and Services
11.10.4. Financial Overview
11.10.5. SWOT Analysis
11.10.6. Key Developments

12. APPENDIX
12.1. ABOUT THE INSIGHT PARTNERS
12.2. GLOSSARY OF TERMS
The List of Companies

1. CSL
2. Merck
3. Rare Disease Therapeutics
4. Flynn Pharma
5. BTG
6. Pfizer
7. Haffkine Bio-Pharmaceutical
8. MicroPharm
9. Vins Bioproducts
10. Bharat Serums and Vaccines
TIPRE00024651
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing

Free

20%

customization on Pre-Booking